Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
002099.SZ Stock Price Chart
Explore Zhejiang Hisoar Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002099.SZ price movements and trends.
002099.SZ Company Profile
Discover essential business fundamentals and corporate details for Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
26 Dec 2006
Employees
2.61K
Website
https://www.hisoar.comCEO
Guorui Xu
Description
Zhejiang Hisoar Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells fine chemicals and special raw drugs in China and internationally. It offers antibiotic, anti-virus, cardiovascular, sugar-reducing, and other materials; and medicine intermediates, and other customized and processed products, such as clindamycin, 4-AA Iso-carbapenem series, thiamphenicol, florfenicol, voglibose, eclindamycin, 4-AA iso-carbapenem, thiamphenicol, florfenicol, voglibose, etc. It also exports its products. The company was founded in 1966 and is based in Taizhou, China.
002099.SZ Financial Timeline
Browse a chronological timeline of Zhejiang Hisoar Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 29 Apr 2025
EPS came in at -¥0.27 , while revenue for the quarter reached ¥493.99M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.01 , while revenue for the quarter reached ¥486.43M .
Earnings released on 30 Oct 2024
EPS came in at -¥0.02 , while revenue for the quarter reached ¥405.64M .
Earnings released on 30 Aug 2024
EPS came in at ¥0.00 , while revenue for the quarter reached ¥510.38M .
Earnings released on 20 May 2024
EPS came in at ¥0.02 , while revenue for the quarter reached ¥528.46M .
Earnings released on 28 Apr 2024
EPS came in at -¥0.29 , while revenue for the quarter reached ¥495.26M .
Earnings released on 30 Oct 2023
EPS came in at -¥0.04 , while revenue for the quarter reached ¥480.19M .
Earnings released on 29 Aug 2023
EPS came in at -¥0.01 , while revenue for the quarter reached ¥562.39M .
Dividend declared on 24 May 2023
A dividend of ¥0.05 per share was announced, adjusted to ¥0.05. The dividend was paid on 24 May 2023.
Earnings released on 24 Apr 2023
EPS came in at -¥0.05 , while revenue for the quarter reached ¥633.05M .
Earnings released on 31 Mar 2023
EPS came in at ¥0.03 , while revenue for the quarter reached ¥634.05M .
Earnings released on 1 Nov 2022
EPS came in at ¥0.02 , while revenue for the quarter reached ¥603.28M .
Earnings released on 1 Sept 2022
EPS came in at ¥0.05 , while revenue for the quarter reached ¥663.28M .
Dividend declared on 25 May 2022
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 25 May 2022.
Earnings released on 27 Apr 2022
EPS came in at ¥0.05 , while revenue for the quarter reached ¥804.53M .
Earnings released on 24 Apr 2022
EPS came in at ¥0.01 , while revenue for the quarter reached ¥693.64M .
Earnings released on 28 Oct 2021
EPS came in at ¥0.01 , while revenue for the quarter reached ¥602.32M .
Earnings released on 1 Sept 2021
EPS came in at ¥0.00 , while revenue for the quarter reached ¥546.56M .
Dividend declared on 11 Jun 2021
A dividend of ¥0.02 per share was announced, adjusted to ¥0.02. The dividend was paid on 11 Jun 2021.
Earnings released on 29 Apr 2021
EPS came in at -¥0.03 , while revenue for the quarter reached ¥519.25M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.04 , while revenue for the quarter reached ¥642.31M .
Earnings released on 27 Oct 2020
EPS came in at ¥0.06 , while revenue for the quarter reached ¥644.30M .
002099.SZ Stock Performance
Access detailed 002099.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.